Skip to main content
. 2018 Aug 22;17:305. doi: 10.1186/s12936-018-2454-7

Fig. 2.

Fig. 2

Number of individuals receiving parenteral anti-malarial therapy at the Bugoye Level III Health Centre compared to private sector drug shops during the study period (1–31 August 2017)